In about six months, proposals for modified vaccines aimed at omicron subvariants became reality. Here’s a timeline from the waning efficacy of older COVID-19 vaccines to when inoculations began.
A blue gloved hand in the lab holding tubes of blood identified with the label COVID-19 New Variant. The COVID-19 pandemic was the third leading cause of death globally in 2020 and the second in 2021, ...
Figure illustrates the overall symptomatology of Long COVID (panel A), and the shifting prevalence of Long COVID symptoms across SARS-CoV-2 variants, including Wild-type, Alpha, Delta, and Omicron ...
The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...
A new variant, XEC, is emerging in the United States, according to a tracker on the Center for Disease Control's website. The KP.3.1.1 variant, part of the Omicron family, has been the strain ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Mutating virus variant and cell mutation variants as a ...
The World Health Organization (WHO) is keeping an eye on a new COVID-19 variant called NB.1.8.1, or “Nimbus,” that has spread across Europe, the Americas and the Western Pacific. Nimbus is a ...
Symptoms appear to be similar to other COVID variants, the WHO says. Cases of the new COVID-19 variant NB.1.8.1, a descendent of the Omicron variant, are on the rise in some parts of the world, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback